Mother-to-child transmission of HIV-1: Risk factors and prevention

Journal of Biological Regulators and Homeostatic Agents

Volumn 11, Issue 1-2, 1997, Pages 7-10

  Colognesi, C ^a   Tresoldi, E ^a   Salvatori, F ^a   Scarlatti, G ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST FEEDING; CONFERENCE PAPER; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; PREGNANCY; VERTICAL TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030819202     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. World Health Organization. AIDS - Global data. The current global situation of the HIV/AIDS pandemic. Wkly Epidemiol Rec 1994; 69 (26): 189-92.
2. Scarlatti G. Paediatric Human Immunodeficiency Virus Type 1 infection. Lancet 1996 (348):863-8.
3. Courgnaud V, Laure F, Broussard A, et al. Frequent and early in utero HIV-1 infection. AIDS Res Hum Retroviruses 1991; 7: 337-41.
4. Viscarello RR, Cullen MT, DeGennaro NJ, Hobbins JC, Fetal blood sampling in human immunodeficiency virus-seropositive women before elective midtrimester termination of pregnancy. Am J Obstet Gynecol 1992; 167 (4):1075-9.
5. Lewis SH, Reynolds-Kohler C, Fox HE, Nelson JA. HIV-1 in trophoblastic and villous Hofbauer cells, and hematologic precursors in eight week fetuses. Lancet 1990; 335: 565.
6. David FJE, Autran B, Tran HC, et al. Human trophoblast cells express CD4 and are permissive for productive infection with HIV-1. Clin Exp Immunology 1992; 88: 10-6.
7. Fazely F, Sharma PL, Fratazzi C, et al. Simian immunodeficiency virus infection via ammotic fluid: A model to study fetal immunopathogenesis and prophylaxis. J AIDS 1993; 6(2): 107-14.
8. Batman PA, Fleming SC, Sedgwick PM, MacDonald TT, Griffin GE. HIV infection of human fetal intestinal explant cultures induces epithelial cell proliferation. AIDS 1994; 8: 161-7.
9. Bryson YJ, Luzuriaga K, Sullivan JL, Wara DW. Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med 1992; 327: 1246-7.
10. Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992; 340: 585-8.
11. Bertolh J, St. Louis M, Simonds RJ, et al. Esimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire. J Infect Dis 1996; 174: 722-6.
12. Goedert J, Duliege A-M, Amos C, Felton S, Biggar RJ, The international registry of HI V-exposed twins. High risk of HIV-1 infection for first-born twins. Lancet 1991; 338: 1471-5.
13. Douglas GC, King BF. Maternal-fetal transmission of human immunodeficiency virus: A review of possible routes and cellular mechanisms of infection. Clin Infect Diseases 1992; 15: 678-91.
14. de Martino M, Tovo P-A, Tozzi AE, et al. HIV-1 transmission through breast-milk: appraisal of risk according to duration of feeding. AIDS 1992; 6: 991-7.
15. Report of a Consensus Workshop, Siena, Italy. Maternal factors involved in mother-to-child transmission of HIV-1. J. AIDS 1992; 5: 1019-29.
16. Scarlatti G, Hodara V, Rossi P, et al. Transmission of human immunodeficiency virus type 1 (HIV-1) from mother-to-child correlates with viral phenotype. Virology 1993; 197: 624-9.
17. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, Zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. New Eng J Med 1996; 335: 1621-9.
18. Cao Y, Krogstad P, Korber BT, et al. Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant. Nature Med 1997; 3: 549-52.
19. Parekh BS, Shaffer N, Chou-Pong P, et al. Lack of correlation between maternal antibodies to V3 loop peptides of gp120 and perinatal HIV-1 transmission. AIDS 1991; 5 (10): 1179-84.
20. Rossi P, Moschese V, Brolidcn PA, et al. Presence of antibodies to HIV-1 gp120 env epitopes correlates with uninfected status of the children born to seropositive mothers. Proc Natl Acad Sci USA 1989; 86: 8055-8.
21. Scarlatti G, Albert J, Rossi P, et al. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J Infect Dis 1993; 168: 207-10.
22. Choc H, Farzan M, Sun Y, et al. The ß-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996; 85: 1135-48.
23. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokme receptor gene. Nature 1996; 382: 722-5.
24. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996; 273: 1856-62.
25. Ometto L, Zanotto C, Maccabruni A, et al. Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission. AIDS 1995; 9: 427-34.
26. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272: 872-7.
27. Centers for Disease Control. Zidovudine for the Prevention of HIV Transmission from Mother to Infant. Morbid Mortal Wkly Rep 1994; 43(16):285-7.
28. Boyer PJ, Dillon M, Navaie M, et al. Factors predictive of maternal-fetal transmission of HIV-1. JAMA 1994; 271 (24): 1925-30.
29. Villari P, Spino C, Chalmers TC, Sacks HS. Cesarean section to reduce perinatal transmission of human immunodeficiency virus. Online J Curr Clin Trials 1993; 2: doc 74.
30. Expert Group of the Joint United Nations Programme on HIV/AIDS. Implications of HIV variability for transmission: scientific and policy issues. AIDS 1997; 11:UNAIDS1UNAIDS15.
31. Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1α, MIP-1β as the major HIV-suppressive factors produced by CDS+ T cells. Science 1995; 270: 1811-5.
32. Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoatractant SDF-1 is a ligand for LESTR/rusin and blocks HIV-1 entry. Nature 1996; 382: 829-33.
33. Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996; 382: 833-5.
34. Scarlatti G, Tresoldi E, Björndal Å, et al. In vivo evolution of HIV-1 coreceptor usage and sensitivity to chemokine-mediated suppression. Nature Med 1997; in press.
35. Mackewicz CE, Ortega HW, Levy JA. CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J. Clin. Invest. 1991; 87(4): 1462-6.
36. Walker BD, Chakrabarti S, Moss B, et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 1987; 328: 345-8.